About this trial

The study evaluates the effect and safety of Cerebrolysin administered during early rehabilitation in patients with moderate neurological impairment after acute ischemic stroke, conducted at the Department of Vascular Neurology and Intensive Neurological Therapy, UMC Ljubljana.

Eligibility criteria

Qualifiers

None

Disqualifiers

Previous stroke or disability (mRS > 0)

The patient unable to understand instructions

Trial design

Treatments tested in this trial

  • Cerebrolysin treatment
  • Standard treatment (including neurorehabilitation) of acute ischemic stroke

Treatment groups

30 Participants
are divided into 2 treatment groups

Locations

1
UMC Ljubljana - Department of Vascular Neurology and Intensive Neurological Therapy (KOVNINT)1000, Ljubljana Slovenia

Sponsors and collaborators

University Medical Centre Ljubljana

Lead sponsor